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Abstract
Summary: The computational aspects of the problem in this paper involve, ﬁ  rstly, selective mapping of methylated 
DNA clones according to methylation level and, secondly, extracting motif information from all the mapped elements in 
the absence of prior probability distribution. Our novel implementation of algorithms to map and maximize expectation in 
this setting has generated data that appear to be distinct for each lymphoma subtype examined. A “clone” represents a 
polymerase chain reaction (PCR) product (on average ∼500 bp) which belongs to a microarray of 8544 such sequences 
preserving CpG-rich islands (CGIs) [1]. Accumulating evidence indicates that cancers including lymphomas demonstrate 
hypermethylation of CGIs “silencing” an increasing number of tumor suppressor (TS) genes which can lead to 
tumorigenesis.
Availability: Algorithms are available on request from the authors
Contact: papageorgioc@health.missouri.edu
Supplementary Information: available on page 453.
Introduction
Non-Hodgkin’s lymphoma (NHL) is a group of malignancies of the immune system with variable 
clinical behaviors and diverse molecular features. Despite the progress made in classiﬁ  cation of NH–ed 
on classical methods, molecular classiﬁ  cations are a work in progress. Accumulating evidence indicates 
that hypermethylation of CGIs appears to be a prevalent molecular event in human cancers including 
NHLs affecting an increasing number of genes. In order to better understand this widespread phenomenon, 
our laboratory utilized a microarray containing 8544 sequenced CGI clones (on average ≈500 bp in 
length each) to survey the genome-wide methylation present in low-grade NHLs namely chronic 
lymphocytic leukemia (CLL), follicular lymphoma (FL) and mantle cell lymphoma (collectively termed 
small B-cell lymphomas or SBCLs). The data generated in our laboratory by Rahmatpanah F.B. et al. 
[2] revealed that there was diversity in DNA methylation among different SBCL subtypes and some 
genes were preferentially methylated in a subtype-related manner. Therefore, we decided to gather all 
experimentally veriﬁ  ed methylated candidate loci in lymphoma patients in order to map them according 
to their corresponding chromosomal locations. These locations were described by Heisler L.E. et al. 
[3] who sequenced the complete set of 20,736 clones (9K Subset + 12K Subset) derived from a physical 
CGI library prepared by others previously [1, 4–6].
Toward this goal, we designed an algorithm to parse and mine these data in order to examine the 
“randomness” of those differentially methylated candidate loci across the chromosomal landscape. Our 
aim was to examine computationally the “randomness” of those differentially methylated candidate 
loci across the chromosomal landscape and relate any apparent non-random DNA methylation “hot 
spots” on speciﬁ  c chromosomes to potential recurring gene motifs.450
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Physical mapping
For the computational aspect of this project 
involving extraction and reporting of information 
we decided to use Perl language because it is well 
known as the main language for report generation 
and ad hoc data mining [7]. When writing the code, 
we took advantage of Perl’s feature that allowed 
one to use “hard” references to any piece of data 
or code. Indeed, any scalar may hold a hard 
reference. Because arrays and hashes contain 
scalars, one can easily build arrays of arrays, arrays 
of hashes, hashes of arrays, arrays of hashes of 
functions, and so on. We decided to use references 
to variables because of the rather complex data 
structures that had to be parsed and combined.
For data reading and manipulation in Microsoft 
Excel format, the “Comma Separated Values” 
(CSV) ﬁ  le format is still widely used because it 
has a better performance under compression. For 
this reason all spreadsheets in Excel were saved as 
CSV ﬁ  les. Therefore, in order to combine ﬁ  elds of 
data in CSV string and parse CSV strings into a 
workable array, Text:CSV module (version 0.5) 
was utilized (parsing with this module can be done 
in simple array mode, returning a reference to an 
array if the columns are not named).
In order to extract from the data only those 
differentially methylated candidate loci having the 
highest methylation scores by differential meth-
ylation hybridization, we deﬁ  ned a subroutine 
which returned an array of references to an array 
of the extracted columns. Strict pragma and lexical 
variables were used both in the two subroutines 
and the main body of the program. The ouput was 
printed in the terminal in text format as groups of 
identiﬁ  ed methylated loci per chromosome each 
recognized by its name and speciﬁ  c chromosomal 
location.
In order to develop a chromosomal ideogram, 
the MapChart software was downloaded from the 
website at http://www.joinmap.nl [8]. Robust 
non-parametric test for chromosome-wide clustering 
was applied as described previously [2].
Motif extraction
Motifs can be used as “generalized sequences” 
[9, 10] which we can assume to have common 
functionality, e.g. transcription start sites (TSS), 
by deduction through sequence conservation. This 
is the reason why we decided to proceed with a 
sequence-driven algorithm in order to identify 
possible candidate regulatory elements involved, 
perhaps, in DNA methylation of our genes. 
The central computational aspect of the problem 
is extracting motif information in the absence 
of a prior probability distribution. Therefore 
straightforward expectation maximization algo-
rithms of heuristic techniques such as MEME or 
AlignAce, which aid in identifying common motifs 
in sets of unaligned sequences [11, 12] are not 
directly applicable. Instead it is necessary to use a 
machine learning approximation to expectation 
maximization such as K-means, K-nn or C-means 
clustering algorithms. This approach has the 
attractive property that it assumes nothing about 
the distribution of base frequencies and derives the 
distribution from the input sequence data. 
This approach is similar to using a self-organizing 
map [12a]. Implemented properly, these algorithms 
can extract features that are in common among a 
set of objects as well as probability and likelihood 
information over the set of objects.
Motifs were found using an iterative censored 
fuzzy C-means algorithm. Sets of sequences drawn 
from a given disease class were iteratively 
compared with each other, and those areas where 
signiﬁ  cant alignments could be identiﬁ  ed were then 
used to update the sequence probability proﬁ  les. 
The sequence alignments from both possible 
strands were used since either strand of the 
sequence could have a signiﬁ  cant alignment. When 
no alignment could be found, then the sequence 
probability proﬁ  le was moved towards a uniform 
distribution. This process was repeated until a 
stationary state was reached.
After convergence, in addition to reporting the 
profile information, the entropy of the profile 
relative to a uniform distribution was reported. 
Maxima of the entropy correspond to regions 
where the proﬁ  le is least uniform and therefore has 
the most signal. These regions were extracted and 
then examined to see if they were the same in 
different disease classes (see supplementary 
information).
Implementation
Using an algorithmic approach and stricter criteria 
than in earlier work from our laboratory [13] 
(1.5-fold difference between tumor and normal 
tissue; present in 25% of patient samples) two 
aberrantly methylated loci were observed in CLL, 
95 in FL 49 in MCL. Each one of these selected 451
Algorithmic discovery of methylation “hot spots” in DNA from lymphoma patients
Cancer Informatics 2008:6
methylated loci or clones was mapped to its 
genomic location using MapChart
© software. By 
using a robust nonparametric statistical test for 
chromosome-wide methylation localization and 
clustering that takes all loci into consideration, we 
detected statistically significant clustering of 
aberrantly methylated clones on chromosome 2 
(p = 0.0005), 9 (p = 0.0374) and 19 (p = 0.0078) 
in FL only. Using an iterative censored fuzzy 
C-means algorithm we found a set of motifs that 
recur throughout a disease type of the methylated 
loci. We hypothesize that these sites could be tran-
scription factor binding sites acknowledging that 
the probability of a site being a functional site is 
substantially increased when an annotated 
transcription start-site (TSS) is nearby as cata-
loged in the Eukaryotic Promoter Database. 
The computational aspects of the problem in this 
paper involve, ﬁ  rstly, selective mapping of methyl-
ated DNA clones according to methylation level 
and, secondly, extracting motif information from 
all the mapped elements in the absence of prior 
probability distribution. Our novel implementation 
of algorithms to map and maximize expectation in 
this setting has generated data that appear to be 
distinct for each disease type examined.
The 146 differentially methylated candidate loci 
were mapped to their corresponding chromosomal 
locations to examine their “randomness” across 
the chromosomal landscape (Fig. 1).
This process revealed interesting observations. 
Firstly, that the allocations of these clones are well 
distributed across all chromosomes, albeit 
with sparse representation on certain regions 
known to be minimally methylated at a genomic 
level [14, 15]. Secondly, the distribution of these 
hypermethylated loci does not appear to be evenly 
spread across all chromosomal sites. In the present 
study, chromosomes 2 (p = 0.0005), 9 (p = 0.0374) 
and 19 (p = 0.0078) have a statistically signiﬁ  -
cant over-representation of methylated loci in 
only one subtype of our lymphoma patients 
(see supplementary information).
A set of motifs that recur throughout a disease 
type of the methylated sites was derived by this 
process. We hypothesize that these sites could be 
transcription factor binding sites acknowledging 
that the probability of a site being a functional site 
is substantially increased when an annotated TSS 
is nearby as cataloged in the Eukaryotic Promoter 
Database (see supplementary information).
Discussion
Most recent work in our laboratory by Taylor K.H. 
et al. [13] revealed that chromosome 19 has an over-
representation of methylated loci in a large-scale 
analysis of acute lymphoblastic leukemia (ALL) 
patient samples. This, again, is in accordance with 
our present demonstration of chromosome 19 being 
“burdened” by clusters of methylated loci in FL 
patients in a statistically significant way. It is 
interesting to note that chromosome 19 has the 
highest gene density of all human chromosomes, 
more than double the genome-wide average. The 
large clustered gene families, corresponding to high 
G+C content, CGI and density of repetitive DNA 
indicate a chromosome rich in biological and 
evolutionary significance. By comparison, the 
observed clusters of methylated loci in both ALL and 
FL encompass a region on chromosome 19 which is 
believed to harbor TS genes associated with many 
types of cancer including breast, lung, colorectal, 
ovarian and brain. The algorithmic discovery in our 
study of a common motif among methylated loci 
provides a plausible answer to the question about a 
seemingly targeted initiation of methylation that can 
lead to TS genes silencing and human cancer.
Our hypothesis is that a common motif shared by 
the aberrantly methylated loci may be a DNA binding 
site for transcription factors that promote aberrant 
methylation and thus what appears to be a non-random 
targeted methylation. In this way, chromosome 
19 may play a key role in, facilititating the initiation 
and spreading of methylation and TS genes silencing 
leading to neoplastic transformation. Hence, our 
computational approach strengthens and expands 
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Figure 1. Ideogram depicting the “hot spots” discovered on 
chromosomes 2, 9 and 19 that demonstrated statistical signiﬁ  cance 
(loci marked “0” denote genes that have not been investigated yet for 
identity).452
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further the data generated by Taylor et al. as it ﬁ  rst 
conﬁ  rms the importance of chromosome 19 in a 
different lymphoblastic disease like FL and then 
provides a mechanism for possible chromosome-
speciﬁ  c preferential DNA methylation. Data like 
these can be examined not only as a means for early 
diagnosis of cancer but also as biomarkers for 
targeted therapies and monitoring of response to 
treatment.
This brief report demonstrates the power of 
computational and statistical approach to high-
throughput CGI microarray data in cancer 
research. The fact that this particular data analy-
sis is stemming from a study of ∼50% of potential 
CGI sequences in the human genome does not 
diminish the value of discovering chromosomal 
clusters of methylation within lymphoma sub-
classes. By integrating our quantitative microar-
ray data through computational and statistical 
models we aspire to determine sites or “hot spots” 
within the human genome at which we could 
intervene therapeutically at a genetic or epigen-
etic level.
Any apparent non-random DNA methylation 
“hot spots” on speciﬁ  c chromosomes associated 
with speciﬁ  c NHL subtypes should warrant not 
only further studies of the chromatin landscape 
but also clinical correlations prospectively or 
retrospectively with regard to subtype-related 
diagnosis, treatment outcome and prognosis. From 
a cancer treatment standpoint, the effect of 
methylation on silencing tumor-supprressor genes 
is important because it is now possible to reverse 
these changes with DNA methylation inhibitors, 
thereby restoring the tumor-suppressor gene 
function. To avoid misinterpretation of methylation 
data for a single gene, methods like ours that 
comprehensively analyze DNA methylation data 
at the whole-genome level become of utmost 
importance as they help to develop and reﬁ  ne 
epigenetic therapies for cancer.
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